Skip to Content
Merck
CN
  • Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1.

Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1.

European journal of pediatrics (1990-01-01)
E Mönch, J Kneer, C Jakobs, M Arnold, H Diehl, U Batzler
ABSTRACT

In the course of the collaborative study of children treated for PKU, urine samples from a total of 165 patients were analysed at six different times: in the newborn period before onset of therapy, after beginning of dietary management, during and immediately after a protein loading test at 6 months of age. In 95.9% of newborns with elevated Phe levels in plasma, metabolites of this amino acid as well as of Tyr could be detected. Of all metabolites phenylpyruvate always showed the highest concentration, followed by phenyllactate and o-hydroxy-phenylacetate. During the protein loading test an increase of the same metabolites occurred. At the age of 6 months the percentage of p-hydroxylated compounds related to the sum of all metabolites was lower than in the newborn period. Comparing the results of urine analyses at 6 months of age after the protein loading tests with the classification of HPA into the reaction types I-III, it can be clearly stated that patients with the milder forms II and III have already lower levels of Phe metabolites in urine before onset of therapy compared to the reaction type I. In retrospect 52% of the newborns could therefore be classified as reaction type I even before beginning of dietary management. The analysis of urinary Phe metabolites before the onset of therapy therefore provides sufficient information about the reaction type.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Leucine, 99%, FG
Supelco
L-Valine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Leucine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Valine, BioUltra, ≥99.5% (NT)
SAFC
L-Valine
Sigma-Aldrich
2-Hydroxyphenylacetic acid, ReagentPlus®, 99%
Sigma-Aldrich
Mandelic acid, 99%
Sigma-Aldrich
L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Leucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Leucine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Valine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
3-Phenyllactic acid, ≥98%
Supelco
L-Leucine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Leucine, BioUltra, ≥99.5% (NT)
Supelco
L-Phenylalanine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Phenylalanine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Phenylalanine, reagent grade, ≥98%
Sigma-Aldrich
L-Phenylalanine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Phenylpyruvic acid, 98%
Sigma-Aldrich
L-Phenylalanine, 99%, FCC
Sigma-Aldrich
L-(−)-3-Phenyllactic acid, 98%
Sigma-Aldrich
Phenylacetic acid, ≥99%, FCC, FG
Supelco
17α-Hydroxyprogesterone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
L-Phenylalanine, BioUltra, ≥99.0% (NT)
Supelco
DL-Mandelic acid, analytical standard